U-clip Pilot Study in Plastic Surgery
A Prospective Evaluation of U-clips for Arterial Microvascular Anastomoses
1 other identifier
interventional
25
1 country
1
Brief Summary
This study will assess the nitinol U-clip as an alternative to conventional microsurgical suture for arterial anastomoses in free tissue transfer.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for phase_4
Started Oct 2009
Shorter than P25 for phase_4
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
October 1, 2009
CompletedPrimary Completion
Last participant's last visit for primary outcome
October 1, 2010
CompletedStudy Completion
Last participant's last visit for all outcomes
October 1, 2010
CompletedFirst Submitted
Initial submission to the registry
October 7, 2010
CompletedFirst Posted
Study publicly available on registry
October 11, 2010
CompletedMarch 1, 2011
September 1, 2010
1 year
October 7, 2010
February 28, 2011
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Flap failure rate compared to published rate for conventional suture anastomoses
will be measured 3 months postoperative (+/- 2 weeks)
Secondary Outcomes (1)
Rapid, reproducible, sutureless microvascular arterial anastomoses in free flaps without compromising patient outcomes.
data collected at 3 months postoperative (+/- 2 weeks)
Study Arms (1)
no arms
OTHERall patients will receive the treatment - there is only one arms
Interventions
The U-clip is comprised of nitinol, an alloy of nickel and titanium.
Eligibility Criteria
You may qualify if:
- either gender
- any ethnicity
- patient requiring free tissue transfer for complex wound coverage or reconstruction
- patient having arterial anastomotic diameter of at least 2 mm
- patient capable of giving informed consent
You may not qualify if:
- less than 18 years of age
- allergy to nitinol or any of its components (nickel or titanium)
- pregnancy
- known coagulopathy
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Scott and White Hospital and Clinic
Temple, Texas, 76508, United States
Study Officials
- PRINCIPAL INVESTIGATOR
Raman C Mahabir, MD
Scott & White
Study Design
- Study Type
- interventional
- Phase
- phase 4
- Allocation
- NA
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
Study Record Dates
First Submitted
October 7, 2010
First Posted
October 11, 2010
Study Start
October 1, 2009
Primary Completion
October 1, 2010
Study Completion
October 1, 2010
Last Updated
March 1, 2011
Record last verified: 2010-09